Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Homology Medicines stock | $6.19

Learn how to easily invest in Homology Medicines stock.

Homology Medicines Inc is a biotechnology business based in the US. Homology Medicines shares (FIXX) are listed on the NASDAQ and all prices are listed in US Dollars. Homology Medicines employs 205 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Homology Medicines

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FIXX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Homology Medicines stock price (NASDAQ: FIXX)

Use our graph to track the performance of FIXX stocks over time.

Homology Medicines shares at a glance

Information last updated 2021-10-09.
Latest market close$6.19
52-week range$5.94 - $15.24
50-day moving average $7.51
200-day moving average $7.13
Wall St. target price$23.20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.79

Buy Homology Medicines shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Homology Medicines stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Homology Medicines price performance over time

Historical closes compared with the close of $6.19 from 2021-10-14

1 week (2021-10-08) -4.18%
1 month (2021-09-16) -21.65%
3 months (2021-07-16) -3.58%
6 months (2021-04-16) -9.10%
1 year (2020-10-16) -43.47%
2 years (2019-10-16) -54.72%
3 years (2018-10-16) 20.04
5 years (2016-10-12) N/A

Homology Medicines financials

Revenue TTM $33 million
Gross profit TTM $-97,690,000
Return on assets TTM -21.69%
Return on equity TTM -42.74%
Profit margin -271.18%
Book value $3.93
Market capitalisation $368.8 million

TTM: trailing 12 months

Shorting Homology Medicines shares

There are currently 2.3 million Homology Medicines shares held short by investors – that's known as Homology Medicines's "short interest". This figure is 18.2% down from 2.8 million last month.

There are a few different ways that this level of interest in shorting Homology Medicines shares can be evaluated.

Homology Medicines's "short interest ratio" (SIR)

Homology Medicines's "short interest ratio" (SIR) is the quantity of Homology Medicines shares currently shorted divided by the average quantity of Homology Medicines shares traded daily (recently around 495867.10239651). Homology Medicines's SIR currently stands at 4.59. In other words for every 100,000 Homology Medicines shares traded daily on the market, roughly 4590 shares are currently held short.

However Homology Medicines's short interest can also be evaluated against the total number of Homology Medicines shares, or, against the total number of tradable Homology Medicines shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Homology Medicines's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Homology Medicines shares in existence, roughly 40 shares are currently held short) or 0.0594% of the tradable shares (for every 100,000 tradable Homology Medicines shares, roughly 59 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Homology Medicines.

Find out more about how you can short Homology Medicines stock.

Homology Medicines share dividends

We're not expecting Homology Medicines to pay a dividend over the next 12 months.

Homology Medicines share price volatility

Over the last 12 months, Homology Medicines's shares have ranged in value from as little as $5.94 up to $15.24. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Homology Medicines's is -0.4465. This would suggest that Homology Medicines's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Homology Medicines has bucked the trend.

Homology Medicines overview

Homology Medicines, Inc. , a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing across a range of genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, muscle, and eye. Its lead product candidate is HMI-102, which is in Phase I/II pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II. Homology Medicines, Inc.

Frequently asked questions

What percentage of Homology Medicines is owned by insiders or institutions?
Currently 9.139% of Homology Medicines shares are held by insiders and 69.84% by institutions.
How many people work for Homology Medicines?
Latest data suggests 205 work at Homology Medicines.
When does the fiscal year end for Homology Medicines?
Homology Medicines's fiscal year ends in December.
Where is Homology Medicines based?
Homology Medicines's address is: One Patriots Park, Bedford, MA, United States, 01730
What is Homology Medicines's ISIN number?
Homology Medicines's international securities identification number is: US4380831077
What is Homology Medicines's CUSIP number?
Homology Medicines's Committee on Uniform Securities Identification Procedures number is: 438083107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site